Overview

Sphenopalatine Nerve Block for Headache Tx360

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the efficacy of sphenopalatine nerve block utilizing the Tx360 (device) to deliver an anesthetic agent (bupivacaine) and to assess the duration of the analgesia.

Phase:

Phase 3

Details

Lead Sponsor:

Indiana University

Treatments:

Bupivacaine